Based on the suspected tumor type, laboratory tests commonly assess hormone levels such as insulin, gastrin, glucagon, vasoactive intestinal peptide (VIP), and somatostatin to identify functioning PANNETs. This evidence concerns the gene GCG and neoplasm.